Over 100,000 overweight women were studied, and those on GLP-1 medications saw an absolute breast cancer risk reduction of 0.69% during the study period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results